These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7641209)

  • 1. The number of 5-fluoro-2'-deoxyuridine-5'-monophosphate binding sites and reduced folate pool in human colorectal carcinoma tissues: changes after tegafur and uracil treatment.
    Omura K; Kawakami K; Kanehira E; Nagasato A; Kawashima S; Tawaraya K; Watanabe S; Hirano K; Shirasaka T; Watanabe Y
    Cancer Res; 1995 Sep; 55(17):3897-901. PubMed ID: 7641209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers.
    Kawakami K; Omura K; Kanehira E; Watanabe Y
    Anticancer Res; 1999; 19(4B):3249-52. PubMed ID: 10652619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylenetetrahydrofolate reductase polymorphism is associated with folate pool in gastrointestinal cancer tissue.
    Kawakami K; Omura K; Kanehira E; Watanabe G
    Anticancer Res; 2001; 21(1A):285-9. PubMed ID: 11299748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug concentration in cancerous large bowel tissue and thymidylate synthase inhibition rate after administration of tegafur and UFT].
    Futami K; Arima S; Yoshimura S; Okamoto T; Yamasaki K; Koto T; Yamasaki S; Kawahara K; Ikuno T
    Gan To Kagaku Ryoho; 1991 Feb; 18(2):215-20. PubMed ID: 1992915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouracil.
    Spears CP; Gustavsson BG; Berne M; Frösing R; Bernstein L; Hayes AA
    Cancer Res; 1988 Oct; 48(20):5894-900. PubMed ID: 3167844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the pharmacokinetics of UFT in patients with hepatocellular carcinoma associated with cirrhosis].
    Une Y; Ito Y; Ogasawara K; Nagafuchi E; Matsuoka S; Misawa K; Sato N; Nakajima Y; Uchino J
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3153-9. PubMed ID: 2551251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophosphamide augments the anti-tumor efficacy of uracil and tegafur by inhibiting dihydropyrimidine dehydrogenase.
    Nio Y; Iguchi C; Kodama H; Itakura M; Hashimoto K; Koike M; Toga T; Maruyama R; Fukushima M
    Oncol Rep; 2007 Jan; 17(1):153-9. PubMed ID: 17143493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of in vivo antitumor activities of fluorinated pyrimidines to thymidylate synthase activity and intratumoral concentrations of 5-fluorouracil and uracil.
    Nio Y; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Kawabata K; Imai S; Tobe T
    Anticancer Res; 1991; 11(2):607-12. PubMed ID: 2064315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 5-fluorouracil derivative UFT on thymidylate synthetase and thymidine kinase in rat colorectal tumors.
    Sakamoto S; Kawachi Y; Iwama T; Kuwa K; Suzuki T; Mitamura T; Kudo H; Sassa S; Yoshimura S; Maemura T; Nakayama T; Ohsawa M; Hara Y
    Anticancer Res; 1999; 19(1A):245-50. PubMed ID: 10226549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral induction of thymidylate synthase mRNA by 5-FU in colorectal cancer patients: association with survival.
    Tanaka-Nozaki M; Tajiri T; Tanaka N; Furukawa K; Takasaki H; Yoshimura K; Suzuki H; Naito Z; Sugizaki Y; Merk HF; Blömeke B; Kato S
    Oncol Rep; 2003; 10(5):1425-9. PubMed ID: 12883718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Innate resistance to thymidylate synthase inhibition after 5-fluorouracil treatment--a rationale of combined use of cisplatin and its optimal administration dose].
    Omura K; Hashimoto T; Kawakami K; Kanehira E; Watanabe T; Hirano K; Watanabe S; Watanabe Y; Shirasaka T
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):2007-11. PubMed ID: 8085851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes of the number of FdUMP binding sites of thymidylate synthase and folate pools in human colorectal carcinomas following the administration of tegafur and uracil: preliminary report].
    Omura K; Kawakami K; Ishida F; Hashimoto T; Matsu T; Adachi I; Watanabe Y
    Nihon Geka Gakkai Zasshi; 1993 Feb; 94(2):193. PubMed ID: 8464418
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thymidylate synthase inhibition in malignant tumors after oral administration of UFT].
    Yamamura M; Seiro T; Yamamoto M; Shirasaka T; Miyauchi S; Fujii S
    Gan No Rinsho; 1986 Nov; 32(14):1838-40. PubMed ID: 3099031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thymidylate synthase inhibition and concentration of 5-fluorouracil after administration of UFT in human uroepithelial carcinomas].
    Kanimoto Y; Suzuki Y; Miwa Y; Akino H; Isomatu Y; Okada K
    Hinyokika Kiyo; 1991 Mar; 37(3):229-33. PubMed ID: 1648873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biphasic binding of 5-fluoro-2'-deoxyuridylate to human thymidylate synthase.
    Reilly RT; Barbour KW; Dunlap RB; Berger FG
    Mol Pharmacol; 1995 Jul; 48(1):72-9. PubMed ID: 7623777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Level of inhibition of thymidylate synthase activity and 5-fluorouracil in tumor tissues after administration of UFT or tegafur].
    Suzuki M; Sekiguchi I; Tamada T; Nishida M
    Nihon Gan Chiryo Gakkai Shi; 1989 Jul; 24(7):1399-404. PubMed ID: 2530293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors.
    Johnston PG; Lenz HJ; Leichman CG; Danenberg KD; Allegra CJ; Danenberg PV; Leichman L
    Cancer Res; 1995 Apr; 55(7):1407-12. PubMed ID: 7882343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of neo-adjuvant chemotherapy with UFT (a combination of tegafur and uracil) on DNA-synthesizing enzyme activities in human colorectal carcinomas].
    Sakamoto S; Kudo H; Kuwa K; Kawasaki T; Kasahara N; Okamoto R; Sagara T; Kawachi Y; Iwama T; Hirayama R
    Nihon Gan Chiryo Gakkai Shi; 1989 Jan; 24(1):94-8. PubMed ID: 2500492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
    van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
    Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of thymidylate synthase gene expression in human gastrointestinal carcinoma tissues using competitive PCR.
    Omura K; Morishita M; Kawakami K; Kanehira E; Ishida Y; Watanabe Y
    Hepatogastroenterology; 1999; 46(26):985-90. PubMed ID: 10370652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.